| EN
Trends and Opportunities for Hospital Investments 医院投资的发展趋势与机遇
2017年9月15日 星期五 18:30 至 21:00
商务休闲
Yale Center Beijing, 36F, Tower B, IFC Building, 8 Jianguomenwai Avenue 耶鲁北京中心,建国门外大街8号,国际财源中心B座36层 (永安里地铁站C出口)
主办方: Yale Healthcare Club of China 更多活动

价格: ¥20 - 80

Trends and Opportunities for Hospital Investments 医院投资的发展趋势与机遇

价格: ¥20 - 80

Trends and Opportunities for Hospital Investments 医院投资的发展趋势与机遇
2017年9月15日 星期五 18:30 至 21:00
商务休闲
Yale Center Beijing, 36F, Tower B, IFC Building, 8 Jianguomenwai Avenue 耶鲁北京中心,建国门外大街8号,国际财源中心B座36层 (永安里地铁站C出口)
主办方: Yale Healthcare Club of China 更多活动

价格: ¥20 - 80

9月15日

周五

Trends and Opportunities for Hospital Investments 医院投资的发展趋势与机遇

2017年9月15日 星期五 18:30 至 21:00 Yale Center Beijing, 36F, Tower B, IFC Building, 8 Jianguomenwai Avenue 耶鲁北京中心,建国门外大街8号,国际财源中心B座36层 (永安里地铁站C出口)

价格: ¥20 - 80

时间 地点

2017年9月15日 星期五 18:30 至 21:00

Yale Center Beijing, 36F, Tower B, IFC Building, 8 Jianguomenwai Avenue 耶鲁北京中心,建国门外大街8号,国际财源中心B座36层 (永安里地铁站C出口)
Yale Center Beijing, 36F, Tower B, IFC Building, 8 Jianguomenwai Avenue 耶鲁北京中心,建国门外大街8号,国际财源中心B座36层 (永安里地铁站C出口)
活动二维码

用微信客户端扫描并分享此活动

主办方 联系主办方

Yale Healthcare Club of China

Yale Healthcare Club of China

查看更多

YaleHealthcareChina@outlook.com

访问主办方主页

活动细节

浏览: 4,821

Trends and Opportunities for Hospital Investments

医院投资的发展趋势与机遇


Introduction

未来医院投资的发展趋势和机遇在哪里?投资者在未来的投资并购策略是怎样的?投资者在投后管理的过程中面临的主要挑战是什么?如何应对?围绕这一系列的热点问题,耶鲁大学医疗健康中国校友俱乐部(YHCC)邀请了在医院投资领域的资深投资人,分享他们对医院投资的见解。


Panelists will discuss: What are the trends and opportunities in hospital investing? What are the principal strategies and tactics investors might adopt when making hospital investments? What are the strategies for managing and adding value to hospital investments


由深圳信立泰药业股份有限公司赞助,耶鲁北京中心、耶鲁医疗健康中国校友俱乐部合办

Sponsored by the Shenzhen Salubris Pharmaceuticals Co., Ltd., co-hosted by the Yale Center Beijing & Yale Healthcare Club of China

 

Panelists/嘉宾:

Bing Yuan 袁兵 (Yale JD '98)

Managing Director at Hony Capital

弘毅投资董事总经理


Tingjun Liu 刘挺军

Vice President of Taikang Insurance Group, CEO of Taikang Community Investment Co., Ltd.

泰康保险集团副总裁兼泰康之家投资有限公司首席执行官


Bo Yu 禹勃

Founding Partner and Chairman of Ch-Gemstone Capital, Chairman of Ham’s Company, Chairman of Ch-Gemstone Medical Group and Chairman of Ch-Gemstone Healthcare Holdings.

中钰资本创始合伙人,金字火腿董事长,中钰医生集团董事长,中钰医疗控股董事长


Kai Zhao 赵凯

Managing Partner at Cenova Capital

千骥资本管理合伙人


Moderator/主持人:

Selina Zhang 张思思 (Yale SOM '04)

Former Founding Partner of Private Equity Business at Meritco Services, Managing Director of Yale Healthcare Club of China

前久谦咨询私募基金咨询业务创始合伙人和医疗服务团队负责人,耶鲁大学医疗健康中国校友俱乐部董事总经理


Event details:

Date/日期:

Friday, September 15th

9月15日,星期五

Time/时间:

Registration & Reception/注册

6:30-7:00 pm

Panel Discussion and Q&A嘉宾讨论与问答

7:00-9:00 pm

Venue/地点:

Yale Center Beijing, 36F, Tower B, IFC Building, 8 Jianguomenwai Avenue

耶鲁北京中心,建国门外大街8号,国际财源中心B座36层 (永安里地铁站C出口)

http://map.baidu.com/?shareurl=1&poiShareUid=520ec2b99a6b6484921fc9b5&cityCode=131&tn=B_NORMAL_MAP

Ticket/门票:

Purchase in advance: RMB 20 for students; RMB 60 for Yale alumni; RMB 80 for others.

Purchase at the door: RMB 100.

提前报名:学生票20元;耶鲁校友60元;普通门票80元。

现场报名:100元。


The language of the event will be Chinese.

活动语言为中文。

 

About Panelists

Bing Yuan 袁兵 (Yale JD '98)

Mr. Yuan joined Hony Capital as a Director in April 2009 and was promoted to Managing Director in January 2010. Mr. Yuan is in charge of PE Investment Management Department at Hony, which oversees the private equity investment activities. Prior to joining Hony, Mr. Yuan was a Managing Director in Morgan Stanley Principal Investments based in Hong Kong and is responsible for Morgan Stanley’s principal investment activities in China. Prior to joining Morgan Stanley Principal Investments, Mr. Yuan was a Managing Director in the China Corporate Finance Group of Morgan Stanley based in Hong Kong. Prior to Morgan Stanley, Mr. Yuan was a Vice President with Credit Suisse First Boston in Hong Kong and New York, focused on corporate finance and merger & acquisitions transactions in the technology, media and telecom industry. Mr. Yuan assisted numerous prominent Chinese SOE and private sector companies in successfully completing their IPO, corporate finance and M&A transactions. Before that, Mr. Yuan has also worked as a financial analyst in project finance with Fieldstone Private Capital Group, L.P. in New York.

Mr. Yuan graduated from Nanjing University with a BS in English in 1990; he received a Master in International Relations from Yale University in 1993, and a J.D. degree from Yale Law School in 1998.

袁兵先生于2009年4月加入弘毅投资,8个月后升为董事总经理,负责PE业务的管理。加入弘毅投资前,他曾担任摩根士丹利直接投资部董事总经理,驻于香港,负责摩根士丹利在中国的直接投资业务。此前,袁兵先生曾任摩根士丹利中国企业融资业务董事总经理。在加入摩根士丹利之前,袁兵先生任瑞士信贷第一波士顿副总裁,先后于香港和纽约公司工作,负责科技、媒体和电信行业的企业融资和并购,协助众多中国知名的国有和民营企业成功完成了在海外的上市,融资和收购兼并项目。此前,袁兵先生曾在纽约的富通资本担任项目融资的金融分析员。

袁兵先生于 1990 年毕业于南京大学,取得英美文学学士学位,并于 1993 年获耶鲁大学国际关系硕士学位,1998 年获耶鲁大学法学博士学位。


Tingjun Liu 刘挺军

Dr. Liu is currently the Vice President of Taikang Insurance Group, CEO of Taikang Community Invesment Co., Ltd. In 1997, he joined Taikang Life Insurance Co., Ltd. (now Taikang Insurance Group), has served as Chief of strategic planning department, Chief Operating Officer of Taikang Asset Management Co., Ltd. and Chief Executive Officer of Taikang community investment Co., Ltd. Dr. Liu has led Taikang Insurance Group's healthcare industry strategic deployment, and completed strategic investments of the Nanjing Xianlin Gulou Hospital, Taikang Tongji Hospital, and Harmonicare Medical in succession. Dr. Liu was also appointed by the Ministry of Civil Affairs as a member of the National Expert Committee of the endowment service industry, and served as the member of Insurance Asset Management Association of China’s supervisory Board. Dr. Liu obtained Ph.D. degree in Economics from Wuhan University.

刘挺军,武汉大学经济学博士。现任泰康保险集团副总裁兼泰康之家投资有限公司首席执行官。

1997年加入泰康人寿保险有限公司(泰康保险集团前身),先后担任战略企划部负责人、泰康资产管理有限公司首席运营官、泰康之家投资有限公司首席执行官。率领团队推进泰康保险集团的医养产业战略部署,完成全国8个城市的养老社区布局,并先后完成了南京仙林鼓楼医院、泰康同济医院、和美医疗的战略性投资。同时,刘挺军博士还被民政部聘为全国养老服务业专家委员会委员,并担任中国保险资产管理业协会监事会监事等职务。


Bo Yu 禹勃

Mr. Yu, the current Founding Partner of Ch-Gemstone Capital, Chairman of Ham’s, Chairman of Ch-Gemstone Medical Group and Chairman of Ch-Gemstone Healthcare Holdings. Mr. Yu has long been engaged in the field of equity investment in healthcare industry, and has a wealth of experience in the management of pharmaceutical and medical industry. Mr. Yu co-founded Ch-Gemstone Capital in 2013, which has 25.6 billion under management, including 10 Venture Capital Fund funds, 17 Mergers and Acquisitions funds. Mr. Yu served as Chairman of Ham’s in 2017. Prior to this, Mr. Yu had worked in China Food and Drug Administration for many years and served as partner at Kunwu Jiuding Capital until 2013, responsible for the management of several pharmaceutical industry funds. Mr. Yu has led more than 60 successful projects, such as ER-KANG pharmaceutical, Cisen Pharmaceutical, Cosunter Pharmaceutical, FangSheng Pharmaceutical and so on.

禹勃先生,长期从事于医药医疗大健康产业股权投资领域,具有丰富的医药医疗产业管理经验,现任中钰资本创始合伙人、金字火腿董事长、中钰医生集团董事长、中钰医疗控股董事长。

禹勃先生,曾就读于于沈阳药科大学、中国药科大学等。在原国家医药局、国家药品监督管理局工作多年,曾任九鼎投资合伙人。负责管理多期医药产业基金,带领团队成功投资了六十多个知名项目,如尔康制药,辰欣药业,广生堂,湖南方盛,重庆福安,嘉宝仁和、嘉林药业、郑州邦和等。

2013年创建中钰资本,3年时间成立十只创投基金,17只并购基金,管理规模256亿元,实业控股五家新三板平台。2017年出任上市公司金字火腿董事长,掌舵大健康产业转型。


Kai Zhao 赵凯博士

Dr. Zhao has over 20 years' experience in healthcare management and investment, biomedical research and clinical practice. Before joining Cenova, Dr. Zhao co-founded two hospital management & investment firms. As the head of these two firms, he headed the acquisition of five hospitals in various parts of China, including four tier-2 hospitals and two tier-3 hospitals. Prior to hospital investment, Dr. Zhao was the head of bioscience investment at prominent venture firms in Beijing, where he led their investment into pharmaceuticals and diagnostics. Before his investment career, Dr. Zhao practiced medicine for fourteen years, at a top-tier hospital in China, where he also developed innovative new drugs. Dr. Zhao got his Ph.D. from the Chinese Academy of Military Medical Sciences. He also received his M.D. from the Fourth Military Medical University in China.

赵凯博士拥有超过20年临床医疗、风险投资、医院管理及投资、生物医药研发的成功经验。作为国内第一批从事风险投资的人士,赵凯博士成功投资并管理了多个医疗项目,如北陆药业、深圳微芯生物等,并促成了慈铭体检的A轮投资,还参与组建了北京生物产业孵化基地并出任总经理。赵凯博士还曾先后创立了两家医院管理公司,收购和管理了6家三级和二甲综合性医院,并亲自出任院长。赵凯博士拥有14年的内科医生工作经历。早年毕业于第四军医大学、中国医科大学,获军事医学科学院博士学位并师从吴祖泽院士。


About Moderator

Selina Zhang 张思思 (Yale SOM '04)

Ms. Selina Zhang was a former Founding Partner of Private Equity Business at Meritco Services and in charge of Healthcare Service investment consulting, Managing Director of Yale Healthcare Club of China. Ms. Zhang has over 12 years of experience in private equity (PE) commercial due diligence (CDD) and portfolio management in Beijing, New York, and Los Angeles. Over the past five years, Ms. Zhang has led over 60 PE CDD assignments, deal size ranging from $ 30-100 million. Her representative clients include top global and domestic PE funds as the Carlyle Group, TPG, KKR, Hillhouse Capital, Sequoia Capital, Temasek, Morgan Stanley, the CITIC PE, and Tencent, etc. Ms. Zhang was also in charge of healthcare service business line at Meritco. She completed over 30 projects of hospital CDDs, hospital strategy, and greenfield hospital planning. Targets include public and private Class II and III hospitals ranging from 200 to 1000 beds. Prior to Meritco Services, Ms. Zhang was in charge of PE practice at Copal Partners, now currently a subsidy of Moody’s. Before moving back to China, Ms. Zhang worked at the strategy division at PwC, New York Office. Ms. Selina Zhang earned MBA degree from Yale School of Management in 2004.

张思思,前久谦咨询私募基金咨询业务创始合伙人和医疗服务团队负责人,耶鲁大学医疗健康中国校友俱乐部发起人。张女士拥有十二年私募基金商业尽职调查、投后公司发展战略规划及企业并购经验。在过去五年中,张女士主导了超过60个一级市场投资的商业尽职调查与投后企业管理项目,单个交易金额达3000万~1亿美元,行业覆盖包含医疗服务、互联网及大消费领域,服务的客户涵盖国内外数十家顶级私募基金如KKR、凯雷、TPG、高瓴资本、红杉资本、淡马锡、摩根斯坦利、中信产业基金、腾讯等。张女士同时负责久谦医院投资业务,累计完成医院投前商业尽调、投后及新建医院战略规划咨询项目近30个,目标医疗服务机构涵盖公立及民营二、三级医院,病床规模从200余张到1000张不等。加入久谦咨询前,张女士曾分别于Copal Partners(现为Moody’s子公司)担任私募基金业务主管,普华永道纽约战略咨询部担任高级咨询顾问。张女士于2004年获得耶鲁大学MBA学位。

 

About Organizer


Yale Healthcare Club of China (YHCC) comprises of an enthusiastic group Yale alumni working in or interested in the healthcare industry. The YHCC’s mission is to develop networking and business opportunities by connecting Yale alumni to the healthcare business community, and to enhance the community’s knowledge and ideas. In the future, the YHCC will continue to host high-impact and diverse activities, such as panel discussions and speaker series.


耶鲁医疗健康中国校友俱乐部(YHCC, Yale Healthcare Club of China)是由耶鲁大学医疗健康领域的中国校友发起的组织,旨在为会员打造在医疗健康行业的生态圈,促进实业与投资界的沟通与交流,创造更多投资机会。YHCC将定期举办丰富的线上线下活动,涵盖医疗健康领域重要议题,分享领域前沿真知灼见。


展开详情

收起

分享 分享到微信 分享到新浪微博 分享到短信